Susquehanna International Group’s Sophiris Bio, Inc. SPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-10,500
Closed -$10K 11335
2019
Q1
$10K Sell
10,500
-14,800
-58% -$15.9K ﹤0.01% 8661
2018
Q4
$21K Sell
25,300
-34,500
-58% -$67.9K ﹤0.01% 8676
2018
Q3
$167K Sell
59,800
-29,200
-33% -$83.1K ﹤0.01% 8353
2018
Q2
$250K Buy
89,000
+63,000
+242% +$187K ﹤0.01% 8192
2018
Q1
$52K Buy
26,000
+13,000
+100% +$28.2K ﹤0.01% 8945
2017
Q4
$30K Sell
13,000
-10,900
-46% -$23.7K ﹤0.01% 9026
2017
Q3
$51K Sell
23,900
-16,700
-41% -$34.6K ﹤0.01% 8538
2017
Q2
$89K Buy
40,600
+5,000
+14% +$12.2K ﹤0.01% 8738
2017
Q1
$101K Buy
+35,600
New +$97.6K ﹤0.01% 8391

Other funds holding SPHS

Susquehanna International Group's SPHS Position: Q2 2019 in Review

Susquehanna International Group sold out of Sophiris Bio, Inc. (SPHS) in Q2 2019, closing a stake of 14,379 shares — an estimated $14K sold.

Susquehanna International Group first reported a position in SPHS in Q2 2015 and held it in 10 quarters. The position peaked at $74K in Q2 2018. 22 funds tracked by Wall St. Rank hold SPHS as of Q2 2019.

  • Susquehanna International Group reported no remaining Sophiris Bio, Inc. position as of Q2 2019 after selling out during the quarter.
  • Susquehanna International Group sold 14,379 Sophiris Bio, Inc. shares in Q2 2019, an estimated $14K.
  • Susquehanna International Group first reported a position in Sophiris Bio, Inc. in Q2 2015 and held it in 10 quarters.
  • Susquehanna International Group's Sophiris Bio, Inc. position peaked at $74K in Q2 2018.
  • 22 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2019.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.